Advertisement
Screener

Imunon, Inc. (IMNN) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Imunon, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Imunon, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $13.90M went out.
  • Fiscal year ended 2025-12-31: from investing, $280.57K went out.
  • Fiscal year ended 2025-12-31: from financing, $17.09M came in.
  • Fiscal year ended 2025-12-31: change in cash, $2.91M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingDebt paid backNew debtNew shares soldNot split outChange in cash
2025-12-31-$13.90M-$280.57K$13.63M$3.46M*$2.91M
2024-12-31-$18.85M$9.83M$9.06M$34.20K
2023-12-31-$19.02M$11.01M$2.78M-$6.42M*-$11.65M
2022-12-31-$23.10M$8.28M$6.72M-$8.09M
2021-12-31-$16.22M-$30.12M$52.69M$2.08M*$8.42M
2020-12-31-$15.62M$7.92M-$1.32M$1.32M$22.81M-$4.83M*$10.29M
2019-12-31-$20.26M$5.94M$7.84M-$6.48M
2018-12-31-$7.04M-$1.63M$858.51K$9.72M*$1.91M
2017-12-31-$16.64M-$10.99M$36.45M*$8.82M
2016-12-31-$18.38M$9.06M$2.68M*-$6.64M
2015-12-31-$20.83M$13.33M$7.74M-$3.65M*-$3.42M
2014-12-31-$21.35M$9.54M$13.79M$4.99M*$6.97M
2013-12-31-$9.53M-$29.14M$15.62M$13.77M*-$9.27M
2012-12-31-$22.14M$1.47M$697.22K$14.82M*-$5.15M
2011-12-31-$22.74M-$11.09M$48.08M$4.75M*$19.01M
2010-12-31-$13.37M$5.21M$2.48M-$5.78M

Each quarter (3 month)

Quarter endRunning the businessFrom investingDebt paid backNew debtNew shares soldNot split outChange in cash
2026-06-30-$3.03M*$10.16M*
2026-03-31-$3.99M-$3.99M
2025-12-31-$3.66M*-$3.59K*$7.19M*
2025-09-30-$4.44M*$0.00*$3.47M*$1.49M*
2025-06-30-$2.95M*-$17.33K*$2.86M*$1.97M*
2025-03-31-$2.85M-$259.65K$105.69K-$3.00M
2024-12-31-$4.42M*-$14.91K*-$3.28K*
2024-09-30-$4.06M*-$2.88K*
2024-06-30-$4.50M*$7.46M*
2024-03-31-$5.87M$2.38M-$3.49M
2023-12-31-$3.77M*-$3.30M*$30.25K*
2023-09-30-$4.47M*$10.67M*$78.26K*
2023-06-30-$6.79M*$3.23M*$198.56K*-$6.42M*
2023-03-31-$3.98M$416.20K$2.47M-$1.09M
2022-12-31-$5.01M*-$10.88M*$447.31K*
2022-09-30-$4.64M*$4.90M*-$64.02K*
2022-06-30-$5.47M*-$2.49M*
2022-03-31-$7.98M$16.75M$8.78M
2021-12-31-$5.09M*-$974.49K*$1.00*
2021-09-30-$3.79M*$3.01M*$0.00*$0.00*-$8.32K*
2021-06-30-$2.61M*-$17.03M*$13.75M*$566.04K*
2021-03-31-$4.74M-$15.12M$38.94M$1.51M*$20.60M
2020-12-31-$3.73M*-$5.17K*$0.00*$0.00*$2.56M*
2020-09-30-$3.96M*$2.78M*$0.00*$0.00*$2.07M*-$5.20M*
2020-06-30-$2.95M*$7.10M*$12.39M*
2020-03-31-$4.98M-$1.95M$5.79M-$1.13M
2019-12-31-$5.62M*$2.30M*$1.67M*
2019-09-30-$4.48M*$5.28M*$1.71M*
2019-06-30-$4.63M*$4.35M*$2.71M*
2019-03-31-$5.54M-$6.00M$1.75M-$9.78M
2018-12-31$6.09M*$4.27M*-$378.07K*$9.98M*
2018-09-30-$4.27M*-$5.12M*$0.00*-$9.38M*
2018-06-30-$4.21M*$4.95M*-$63.42K*$9.79M*$10.47M*
2018-03-31-$4.66M-$5.74M$1.30M-$9.16M
2017-12-31-$4.21M*-$12.75M*$25.72M*$8.76M*
2017-09-30-$5.11M*$0.00*$4.16M*-$944.03K*
2017-06-30-$4.20M*$100.00K*$3.26M*-$840.54K*
2017-03-31-$3.13M$1.66M$3.32M*$1.85M
2016-12-31-$4.66M*$2.82M*-$1.56M*
2016-09-30-$4.72M*-$2.36M*-$1.04M*-$8.12M*
2016-06-30-$4.25M*-$2.18M*$4.43M*-$2.00M*
2016-03-31-$4.74M$10.78M-$988.49K*$5.05M
2015-12-31-$3.90M*$5.97M*$573.38K*$1.69M*
2015-09-30-$5.32M*$1.96M*-$86.68K*-$924.36K*-$4.38M*
2015-06-30-$5.67M*$3.66M*$6.35M*$4.34M*
2015-03-31-$5.94M$1.74M-$878.44K*-$5.07M
2014-12-31-$6.51M*$14.64M*$0.00*$8.13M*
2014-09-30-$5.84M*$797.88K*$0.00*-$5.04M*
2014-06-30-$4.18M*$4.21M*-$36.42K*$5.00M*$4.99M*
2014-03-31-$4.82M-$10.10M$13.83M-$1.11M
2013-12-31-$3.47M*-$4.46M*-$5.14K*-$7.45M*
2013-09-30-$2.66M*$10.28M*-$12.11K*$7.15M*
2013-06-30-$5.19M*-$17.76M*$8.93M*-$3.60M*
2013-03-31$1.79M-$17.20M$6.71M$14.07M*-$5.38M
2012-12-31-$5.98M*$5.78M*$592.68K*$6.28M*$6.67M*
2012-09-30-$5.25M*-$2.01M*-$95.46K*$3.97M*-$3.39M*
2012-06-30-$5.18M*$2.95M*$4.82M*$2.59M*
2012-03-31-$5.73M-$5.25M$0.00-$11.02M
2011-12-31-$4.44M*-$488.29K*$13.81M*$9.01M*
2011-09-30-$6.91M*-$10.72M*$23.01M*$5.75M*
2011-06-30-$7.03M*-$183.04K*$10.65M*$3.42M*
2011-03-31-$4.37M$301.19K$602.26K$4.29M*$825.62K
2010-12-31-$2.77M*$1.01M*$1.11M*-$685.40K*
2010-09-30-$3.78M*$1.51M*$1.38M*-$920.82K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
SOLIGENIX, INC. (SNGX)United States$0.008B
EXICURE, INC. (XCUR)United States$0.008B-1.54
Traws Pharma, Inc. (TRAW)United States$0.009B-0.58
Alzamend Neuro, Inc. (ALZN)United States$0.009B
Ensysce Biosciences, Inc. (ENSC)United States$0.008B-0.37
InMed Pharmaceuticals Inc. (INM)$0.008B-0.65
Apimeds Pharmaceuticals US, Inc. (APUS)United States$0.008B
FibroBiologics, Inc. (FBLG)United States$0.009B-0.27
CNS Pharmaceuticals, Inc. (CNSP)United States$0.007B
Acurx Pharmaceuticals, Inc. (ACXP)United States$0.007B-0.97